Dr. Oz’s online health site seeks addiction expert, Dr. Cidambi’s views on Probuphine, which was recently approved by the FDA. Probuphine is intended for treatment for opioid dependence and it is used to treat individuals suffering from opiate withdrawal and opiate cravings. Dr. Cidambi, Center for Network Therapy’s medical director argues why Probuphine will flop.
CNT’s Medical Director and leading chemical dependency expert, Indra Cidambi, M.D., helps individuals spot signs of painkiller addiction in a loved one. Fifteen million Americans misuse or abuse prescription painkillers every year almost 4 in 10 people surveyed said they knew someone who was affected by it.